Displaying 3641 - 3660 of 5993
| Contract Number | Brand Code | Brand Name | Active Ingredient | Trade Name | Package Size | Formulary Category | Pkg Price | Unit Price | Unit Description | Max. Reimbursable Quantity / Month | Package Description | Manufacturer Code | Manufacturer Name | Agent Code | Agent Name | Benefit | Therapeutic Code | Therapeutic Desc | Drug Contract Start Date | Drug Contract End Date | Status Description | Default Route | Max Repeats | Therapeutic Head | Amend Date | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 | 5561DE | CANDID V6 100MG VAG PESS (GLP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANDID V6 | 6'S | A | 3.53 | 3.53 | PACK | 1 | BLIS | GLP | GLENMARK PHARMACEUTICALS LTD | CWS | CAPSULE WHOLESALE | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | |||||
| 42 | 5561DF | CANDID V6 2% GEL (GLP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANDID V6 | 30G | A | 6.80 | 6.80 | TUBE | 1 | TUBE | GLP | GLENMARK PHARMACEUTICALS LTD | CWS | CAPSULE WHOLESALE | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | |||||
| 42 | 5561DG | CANDID 500MG VAG PESS (GLP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANDID | 1'S | A | 8.16 | 8.15 | PACK | 1 | BLIS | GLP | GLENMARK PHARMACEUTICALS LTD | CWS | CAPSULE WHOLESALE | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | |||||
| 40 | 5561L | CANESTEN-6 100MG VAG PESS (BSP/AHI) CLOTRIMAZ | CLOTRIMAZOLE | CANESTEN-6 | 6'S | C | 9.00 | 9.00 | VAGINAL PESS | 0 | PACK | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2022-04-01 | 2022-09-30 | VAGINAL | 0 | ANTI-INFECTIVE AGENTS | 2022-03-29 | ||||
| 41 | 5561L | CANESTEN-6 100MG VAG OV (BSP) CLOTRIMAZOLE (C) | CLOTRIMAZOLE | CANESTEN-6 | 6'S | C | 8.92 | 8.9161 | PACK | 1 | BOX | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2024-04-01 | 2026-03-31 | VAGINAL | 0 | AZOLES | |||||
| 42 | 5561L | CANESTEN-6 100MG VAG OV (BSP) CLOTRIMAZOLE (C) | CLOTRIMAZOLE | CANESTEN-6 | 6'S | C | 8.56 | 8.56 | PACK | 1 | BOX | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | 2026-02-11 | ||||
| 40 | 5561Q | CANESTEN-3 2% VAG CR (BSP/AHI) CLOTRIMAZOLE | CLOTRIMAZOLE | CANESTEN-3 | 20G | C | 8.81 | 8.81 | VAGINAL CREA | 1 | TUBE | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2022-04-01 | 2024-03-31 | VAGINAL | 0 | ANTI-INFECTIVE AGENTS | 2022-03-29 | ||||
| 40 | 5561Q | CANESTEN-3 2% VAG CR (BSP/AHI) CLOTRIMAZOLE | CLOTRIMAZOLE | CANESTEN-3 | 20G | A | 10.68 | 10.68 | VAGINAL CREA | TUBE | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 81408 | AZOLES | 2023-02-21 | 2024-03-31 | Add to Contract as Cat A | VAGINAL | 0 | AZOLES | 2023-02-21 | ||||
| 41 | 5561Q | CANESTEN-3 2% VAG CR (BSP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANESTEN-3 | 20G | A | 9.6 | 9.5957 | TUBE | 1 | TUBE | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2024-04-01 | 2026-03-31 | VAGINAL | 0 | AZOLES | |||||
| 42 | 5561Q | CANESTEN-3 2% VAG CR (BSP) CLOTRIM (C) | CLOTRIMAZOLE | CANESTEN-3 | 20G | C | 13.59 | 13.59 | TUBE | 1 | TUBE | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | 2026-02-11 | ||||
| 40 | 5561S | CANESTEN-1 500MG VAG PESS (BSP/AHI) CLOTRIMAZ | CLOTRIMAZOLE | CANESTEN-1 | 1'S | C | 9.38 | 9.38 | VAGINAL PESS | 0 | PACK | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2022-04-01 | 2022-09-30 | VAGINAL | 0 | ANTI-INFECTIVE AGENTS | 2022-03-29 | ||||
| 40 | 5561S | CANESTEN-1 500MG VAG PESS (BSP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANESTEN-1 | 1'S | A | $9.50 | PESSARY | 1 | PESS | BSP | BAYER SCHERING PHARMA AG | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2023-06-06 | 2024-03-31 | VAGINAL | 0 | 2023-06-09 | ||||||
| 41 | 5561S | CANESTEN-1 500MG VAG OV (BSP) CLOTRIMAZOLE | CLOTRIMAZOLE | CANESTEN-1 | 1'S | A | 11.04 | 11.0364 | PACK | 1 | BOX | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2024-04-01 | 2026-03-31 | VAGINAL | 0 | AZOLES | |||||
| 42 | 5561S | CANESTEN-1 500MG VAG OV (BSP) CLOT (C) | CLOTRIMAZOLE | CANESTEN-1 | 1'S | C | 11.04 | 11.04 | PACK | 1 | BOX | BSP | BAYER SCHERING PHARMA AG. | AHI | ARMSTRONG HEALTHCARE INC | 081408 | AZOLES | 2026-04-01 | 2028-03-31 | VAGINAL | 0 | AZOLES | 2026-02-11 | ||||
| 40 | 5581A | HISTAL EXPECTORANT 96MG/ML | 2.5MG/ML SYR (CAR/COL) AMMONIUM CHLORIDE | CHLORPHE More ... | AMMONIUM CHLORIDE|CHLORPHENIRAMINE | HISTAL EXPECTORANT | 2 LITRES | B | 52.52 | 0.03 | SYRUP | 0 | ML | CAR | CARLISLE LABORATORIES LTD | COL | COLLINS LTD | 4816 | EXPECTORANTS | 2022-05-06 | 2024-03-31 | Add to Contract as Cat B | Oral | 0 | RESPIRATORY TRACT AGENTS | 2022-05-06 | |||
| 41 | 5581A | HISTAL EXPECTORANT 96MG/ML|2.5MG/ML SYR (CAR) AMMONIUM CHLOR (B) | AMMONIUM CHLORIDE|CHLORPHENIRAMINE | HISTAL EXPECTORANT | 2 LITRES | B | 62.52 | 0.0313 | ML | 0 | BOTT | CAR | CARLISLE LABORATORIES LTD | COL | COLLINS LTD | 4816 | EXPECTORANTS | 2024-04-01 | 2026-03-31 | ORAL | 0 | EXPECTORANTS | |||||
| 42 | 5581A | HISTAL EXPECTORANT 96MG/ML|2.5MG/ML SYR (CAR) AMMONIUM CHLOR | AMMONIUM CHLORIDE|CHLORPHENIRAMINE | HISTAL EXPECTORANT | 2 LITRES | B | 62.52 | 0.03 | ML | 100 | BOTT | CAR | CARLISLE LABORATORIES LTD | COL | AVENTA BARBADOS | 4816 | EXPECTORANTS | 2026-04-01 | 2028-03-31 | ORAL | 0 | EXPECTORANTS | |||||
| 40 | 5581V | HISTAL DM SYR (CAR/COL) GUAIFE/DEXTRO | DEXTROMETHORPHAN|GUAIFENESIN | HISTAL DM | 2 LITRES | B | 76.11 | 0.04 | SYRUP | 0 | ML | CAR | CARLISLE LABORATORIES LTD | COL | COLLINS LTD | 4816 | EXPECTORANTS | 2022-05-06 | 2024-03-31 | Add to Contract as Cat B | Oral | 0 | RESPIRATORY TRACT AGENTS | 2022-05-06 | |||
| 41 | 5581V | HISTAL DM SYR (CAR) GUAIFE/DEXTRO (B) | DEXTROMETHORPHAN|GUAIFENESIN | HISTAL DM | 2 LITRES | B | 92.42 | 0.0462 | ML | 0 | BOTT | CAR | CARLISLE LABORATORIES LTD | COL | COLLINS LTD | 4816 | EXPECTORANTS | 2024-04-01 | 2026-03-31 | ORAL | 0 | EXPECTORANTS | |||||
| 42 | 5581V | HISTAL DM 3MG/ML|20MG/ML SYR (CAR) DEXTROMETHORPHAN|GUAIFENE | DEXTROMETHORPHAN|GUAIFENESIN | HISTAL DM | 2 LITRES | B | 108.73 | 0.05 | ML | 100 | BOTT | CAR | CARLISLE LABORATORIES LTD | COL | AVENTA BARBADOS | 4816 | EXPECTORANTS | 2026-04-01 | 2028-03-31 | ORAL | 0 | EXPECTORANTS | |||||